News Related to Chronic and Infectious Diseases

Related coverage linked through entity extraction aliases.

Large Molecule Drug Substance CDMO Market Projected to Grow 9% Annually Through 2031

Mar 05, 2026

The large molecule drug substance CDMO market is expected to grow at approximately 9% CAGR through 2031, driven by rising demand for biologics and biosimilars, streamlined regulatory approval pathways, and increasing FDA and EMA approvals for biologic therapies.

AI Transforms Drug Discovery as Market Reaches $31.5 Billion and Phase III Trials Loom

Feb 16, 2026

The drug development services market is projected to reach $31.5 billion in 2026, growing at 12.2% CAGR, while AI-designed drugs enter pivotal Phase III trials that will determine whether the technology can improve clinical success rates beyond the industry's persistent 90% failure rate.